How a Blood Cancer Drug Trial Result Sent a Small-Cap Biotech Stock PlummetingBusiness PenJune 4, 2026June 24, 2026 June 4, 2026June 24, 2026 [stock_market_widget type=”card” template=”basic2″ assets=”ADCT” realtime=”true” api=”yahoo-finance”] Biotech companies often face a defining moment when their most important clinical trial results arrive. This is especially true...